Mumps is a contagious viral illness best known for causing painful swelling of the parotid glands, one of the major salivary glands located near the jaw and ears. While the introduction of the measles, mumps, and rubella (MMR) vaccine has significantly reduced cases worldwide, outbreaks continue to occur, especially in areas with low vaccination rates or waning immunity. Mumps is more than just a childhood disease—it can affect adolescents and adults, sometimes leading to serious complications like orchitis (inflammation of the testicles), meningitis, oophoritis (ovarian inflammation), pancreatitis, and in rare cases, permanent hearing loss or infertility. 

This article provides a comprehensive, evidence-based overview of mumps, including its causes, risk factors, epidemiology, clinical features, complications, diagnosis, management, prevention, and prognosis. By understanding the full picture, patients, families, and healthcare providers can better recognize, treat, and prevent this vaccine-preventable disease. 

Mumps is an infectious disease caused by the mumps virus, a member of the Paramyxoviridae family within the Rubulavirus genus. The hallmark symptom is swelling and pain in the salivary glands, especially the parotid glands, which can lead to noticeable puffiness near the jawline. However, the virus can also spread to other organs, causing systemic illness. 

Although mumps is preventable with the MMR vaccine, outbreaks still occur in communities with insufficient immunization or in individuals with waning immunity. Unlike bacterial parotitis, which typically affects one gland and produces pus, mumps is viral and often affects both glands without purulent discharge. 

Common conditions include: Congenital Mumps

Mumps is caused by exposure to the mumps virus, typically through respiratory droplets or direct contact with saliva. Several risk factors increase the likelihood of infection: 

• Lack of vaccination: Individuals who have not received the MMR vaccine are at highest risk. 

• Incomplete vaccination: People with only one dose may have partial protection but remain vulnerable. 

• Waning immunity: Even fully vaccinated individuals can become susceptible as immunity declines over time. 

• Close-contact environments: Schools, colleges, military barracks, and sports teams often see outbreaks due to crowding. 

• Global travel: Visiting areas with lower vaccination coverage can increase exposure risk. 

After entering the body through the nose or mouth, the mumps virus follows a predictable course: 

1. Entry and replication: The virus replicates in the respiratory tract and nearby lymph nodes. 

2. Viremia: It spreads through the bloodstream to various organs. 

3. Target organs: The salivary glands, pancreas, gonads, and central nervous system are particularly vulnerable. 

4. Inflammation: The immune response causes the painful swelling characteristic of mumps. 

This systemic spread explains why mumps can lead to complications beyond the salivary glands. 

Before widespread vaccination, mumps was nearly universal among children. Today, its prevalence has dropped dramatically in regions with high vaccine uptake. However, cases persist worldwide due to uneven coverage and waning immunity. 

Key epidemiological points: 

• Global decline: In countries with robust vaccination programs, mumps incidence has dropped by more than 99%. 

• Age distribution shift: Outbreaks increasingly occur among adolescents and young adults, especially on college campuses. 

• Global hotspots: Mumps remains common in countries with poor vaccine coverage. 

• Seasonality: Historically, cases peaked in late winter and spring. 

• Outbreak risk: Crowded environments remain high-risk for transmission even in vaccinated groups. 

Mumps can range from silent infection to severe illness. About 20–30% of infected individuals show no symptoms, making it easier for the virus to spread unnoticed. For symptomatic cases, the illness follows a classic course: 

Prodromal symptoms (1–2 days before swelling): 

• Low-grade fever 

• Headache 

• Fatigue 

• Loss of appetite 

• Muscle aches 

Classic parotitis (salivary gland swelling): 

• Painful swelling of one or both parotid glands 

• Puffiness near the jaw and ear 

• Pain that worsens with chewing or sour foods 

• Redness and swelling at Stensen’s duct opening inside the mouth 

Other symptoms: 

• Ear pain 

• Difficulty swallowing 

• Jaw stiffness (trismus) 

Because vaccinated individuals may present with milder or atypical symptoms, laboratory testing is often needed to confirm mumps in outbreak settings. 

Mumps is usually diagnosed clinically based on parotid gland swelling lasting at least two days, especially during an outbreak. However, laboratory confirmation is crucial in atypical cases or in vaccinated patients. 

Diagnostic tools include: 

• RT-PCR (preferred): Detects viral RNA from saliva, throat swabs, or urine. Most accurate within 3 days of symptom onset. 

• Serology: Measures mumps-specific IgM and IgG antibodies. IgM may be absent in previously vaccinated individuals. 

• CSF analysis: Used if meningitis is suspected; typically shows elevated lymphocytes and normal to low glucose. 

Differential diagnosis for Mumps 

Several other illnesses can resemble mumps, so doctors must carefully consider these when making a diagnosis. Common mimics include bacterial parotitis, salivary duct stones, and other viral infections. Recognizing these distinctions helps avoid misdiagnosis and ensures proper treatment. 

• Bacterial parotitis: Usually unilateral with pus discharge. 

• Other viral infections: Influenza, parainfluenza, or coxsackievirus. 

• Salivary duct obstruction (sialolithiasis): Painful swelling due to stones. 

• Cervical lymphadenitis: Enlarged neck lymph nodes. 

• Suppurative parotitis: Bacterial infection causing pus and abscess formation. 

There is no specific antiviral treatment for mumps. Care focuses on relieving symptoms and preventing complications. 

General management: 

• Isolate for at least 5 days after onset of swelling 

• Rest and hydration 

• Pain relief with acetaminophen or NSAIDs 

• Warm or cold compresses for swollen glands 

• Soft diet to minimize chewing discomfort 

Managing complications: 

• Orchitis: Bed rest, scrotal support, ice packs, and pain relief; corticosteroids may be considered in severe cases. 

• Meningitis/encephalitis: Supportive care, monitoring neurological function. 

• Pancreatitis: IV fluids, pain management, and rest. 

Most patients recover fully within 1–2 weeks, but complications may require hospitalization. 

Mumps complications are more likely in adolescents and adults than in children. While most patients recover completely, some outcomes can be serious: 

Neurological complications: 

• Aseptic meningitis (1–10% of cases) 

• Encephalitis (rare but serious) 

• Sensorineural hearing loss (about 1 in 20,000 cases) 

Reproductive complications: 

• Orchitis in 20–30% of post-pubertal males (rarely causes infertility but may reduce fertility) 

• Oophoritis and mastitis in 5% of post-pubertal females 

Other complications: 

• Pancreatitis 

• Arthritis (temporary) 

• Rare: myocarditis, nephritis 

In pregnancy: 

• Increased risk of miscarriage in the first trimester 

• No strong link to congenital malformations 

For most people, mumps is a self-limiting illness with full recovery within 10 days. Complications are uncommon but can have lasting effects, particularly hearing loss and reduced fertility in men who develop orchitis. Vaccination dramatically reduces the risk of severe illness and complications. 

The cornerstone of prevention is vaccination with the MMR vaccine: 

MMR vaccine details: 

• Live-attenuated virus given by injection 

• First dose: 12–15 months of age 

• Second dose: 4–6 years of age 

• Effectiveness: ~78% after one dose, ~88% after two doses 

Other preventive measures: 

• Handwashing and respiratory hygiene (covering coughs/sneezes) 

• Isolating infected individuals during the contagious period 

• Third MMR dose may be given during outbreaks to boost immunity in high-risk groups 

Public health strategies: 

• Surveillance of cases and outbreaks 

• Rapid vaccination campaigns in outbreak settings 

• Combating vaccine misinformation to maintain herd immunity 

For most, living with mumps involves a brief period of discomfort, swelling, and the need to limit contact with others. This isolation can feel inconvenient, but it is key to preventing the spread of infection. Supportive care—such as hydration, rest, and pain relief—helps ease symptoms and promotes recovery. 

• Rest and stay hydrated 

• Use compresses for gland pain 

• Stick to a soft, non-acidic diet 

• Avoid close contact with others until at least 5 days after swelling begins 

For those with complications like orchitis or hearing loss, ongoing medical follow-up may be needed. Emotional support and clear communication with healthcare providers can ease anxiety during illness. 

Mumps is a vaccine-preventable viral illness that still poses risks worldwide due to waning immunity, incomplete vaccination, and ongoing outbreaks. While often mild, it can cause significant complications, especially in adolescents and adults. Vaccination remains the most effective tool for prevention, but awareness of symptoms, timely diagnosis, and supportive care are equally important. 

Ongoing global efforts to expand vaccine access, maintain high coverage, and address vaccine hesitancy are crucial to reducing the burden of mumps and preventing its serious complications. 

1. Rubin SA, Plotkin SA. Mumps vaccine. In: Plotkin’s Vaccines. 8th ed. Elsevier; 2021:353-369. 
2. CDC. Mumps. Epidemiology and Prevention of Vaccine-Preventable Diseases. The Pink Book. 14th ed. 2021. 
3. WHO. Mumps Fact Sheet. https://www.who.int/news-room/fact-sheets/detail/mumps 
4. Hviid A, Rubin S, Mühlemann K. Mumps. Lancet. 2008;371(9616):932-944. 
5. Clemmons NS, Lee AD, Lopez A, et al. Mumps: Recent Outbreaks and Vaccine Effectiveness. Curr Epidemiol Rep. 2018;5(2):86-93.